Literature DB >> 11280074

Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar.

C Roussilhon, J L Pérignon, P Druilhe.   

Abstract

Premunition, naturally acquired protective immunity against Plasmodium falciparum, has been described in hyperendemic areas of Africa and Papua New Guinea. However, its occurrence in Asia is debatable. In order to elucidate this question, a longitudinal study was undertaken in Oo-Do, a malaria endemic village in Myanmar [Burma] in 1995-97. Only 2 species, Plasmodium falciparum and P. vivax, were detected, with the former predominating. Data from 116 subjects showed that all were infected at one time or another, over a period of 3 years, with a 38% reinfection rate after eradication of patent parasitaemia. The high rate of prevalence (90-100%) of parasite-specific antibodies in the indirect immunofluorescence antibody test and the presence of the primary vector (Anopheles minimus) and 15 other species of Anopheles throughout the year indicated a high level of transmission. The spleen rate was 70% in 5-9 years old children and was inversely related with age. The incidence of parasitaemia was maximal (49%) in children aged 2-4 years, and then declined marginally with age. There was a significant difference (P = 0.001) between the asymptomatic and febrile parasitaemia levels. Also, malarial episodes occurred more frequently in children than in adults (P = 0.001). Taken together, all these facts indicated that the inhabitants of Oo-Do had progressively developed non-sterile partial protective immunity against P. falciparum malaria, or premunition. To our knowledge, this is the first detailed clinico-epidemiological study to document the occurrence of premunition in Myanmar.

Entities:  

Mesh:

Year:  2001        PMID: 11280074     DOI: 10.1016/s0035-9203(01)90342-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  17 in total

1.  Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria.

Authors:  Ton That Ai Long; Shusuke Nakazawa; Maria Cecilia Huaman; Hiroji Kanbara
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 2.  Malaria vector control: from past to future.

Authors:  Kamaraju Raghavendra; Tapan K Barik; B P Niranjan Reddy; Poonam Sharma; Aditya P Dash
Journal:  Parasitol Res       Date:  2011-01-13       Impact factor: 2.289

3.  Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties.

Authors:  Rasmus Lundquist; Leif Kofoed Nielsen; Ali Jafarshad; Daw Soesoe; Lars Harder Christensen; Pierre Druilhe; Morten Hanefeld Dziegiel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.

Authors:  Method D Segeja; Bruno P Mmbando; Misago D Seth; John P Lusingu; Martha M Lemnge
Journal:  BMC Infect Dis       Date:  2010-03-08       Impact factor: 3.090

6.  Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.

Authors:  Ester C Sabino; Tzong-Hae Lee; Lani Montalvo; Megan L Nguyen; David A Leiby; Danielle M Carrick; Marcia M Otani; Elizabeth Vinelli; David Wright; Susan L Stramer; Michael Busch
Journal:  Transfusion       Date:  2012-09-25       Impact factor: 3.157

Review 7.  Immune checkpoint blockade in infectious diseases.

Authors:  Michelle N Wykes; Sharon R Lewin
Journal:  Nat Rev Immunol       Date:  2017-10-09       Impact factor: 53.106

8.  Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.

Authors:  Tyler Brown; Linda S Smith; Eh Kalu Shwe Oo; Kum Shawng; Thomas J Lee; David Sullivan; Chris Beyrer; Adam K Richards
Journal:  Malar J       Date:  2012-09-19       Impact factor: 2.979

9.  Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria.

Authors:  Romuald Dassé; Didier Lefranc; Sylvain Dubucquoi; Patricia Dussart; Virginie Dutoit-Lefevre; Boualem Sendid; François Sombo Mambo; Patrick Vermersch; Lionel Prin
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-12-29

10.  Prevalence of Plasmodium falciparum in active conflict areas of eastern Burma: a summary of cross-sectional data.

Authors:  Adam K Richards; Linda Smith; Luke C Mullany; Catherine I Lee; Emily Whichard; Kristin Banek; Mahn Mahn; Eh Kalu Shwe Oo; Thomas J Lee
Journal:  Confl Health       Date:  2007-09-05       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.